Chair: M. Al Zaidi (Bonn), P. Nordbeck (Würzburg)
| (V446) | Mitochondrial dysfunction in aortic valvular cells in experimental aortic valve stenosis | |
| P. Leuders, S. Will, J. Hoffe, M. Grandoch, M. Kelm, T. Zeus, C. Quast (Düsseldorf) | ||
| Diskussion | ||
| (V447) | Sortilin Drives Valvular Interstitial Cells to a Combined Inflammatory Myofibroblastic-Osteogenic Phenotype in Calcific Aortic Valve Disease | |
| F. Schlotter, F. Iqbal, D. Becker-Greene, L. Adrien, C. Goettsch, J. Hutcheson, M. Rogers, S. Ito, A. Halu, L. H. Lee, M. Blaser, A. Mlynarchik, S. Hagita, S. Kuraoka, H. Y. Chen, J. Engert, L. Passos, P. Jha, E. Osborn, F. Jaffer, S. Body, S. Robson, G. Thanassoulis, M. Aikawa, S. Singh, A. Sonawane, E. Aikawa (Leipzig, Aachen, Boston; Boston, Miami, US; Montreal, CA) | ||
| Diskussion | ||
| (V448) | The role of Toll-like receptor 3 in aortic valve calcification and endothelial to mesenchymal transition | |
| N. Willemsen, M. Bulic, S. T. Niepmann, A. Zietzer, A.-S. Boucher, G. Nickenig, S. Zimmer (Bonn) | ||
| Diskussion | ||
| (V449) | Investigating the role of long non-coding RNA H19 on endothelial to mesenchymal transition in aortic valve stenosis | |
| K. Maus, F. Jansen, M. R. Hosen (Bonn) | ||
| Diskussion | ||
| (V450) | Myocardial proteome profiling reveals disease- and sex-specific alterations in patients with aortic valve stenosis and mitral valve regurgitation | |
| S. Nordmeyer, M. Kraus, M. Ziehm, M. Kirchner, M. Schafstedde, M. Kelm, S. Niquet, M. M. Stephen, I. Baczko, C. Knosalla, M. Schapranow, G. Dittmar, M. Gotthardt, M. Falcke, V. Regitz-Zagrosek, T. Kühne, P. Mertins (Berlin, Potsdam; Szeged, HU; Strassen, LU) | ||
| Diskussion |
